319 results match your criteria IAPAC Monthly[Journal]


PEG-IFN, RBV dosing during chronic HCV re-treatment.

Authors:
Liz Highleyman

IAPAC Mon 2007 Feb;13(2):55

View Article

Download full-text PDF

Source
February 2007
2 Reads

Risks higher in GTI at higher CD4 threshold.

Authors:
Derek Thaczuk

IAPAC Mon 2007 Feb;13(2):39-40

View Article

Download full-text PDF

Source
February 2007
1 Read

Mixed co-receptor use associated with lower CD4 count.

IAPAC Mon 2007 Feb;13(2):38-9

View Article

Download full-text PDF

Source
February 2007
1 Read

Focus on hepatitis. HIV/HCV coinfection and CVD risk.

Authors:
Michael Carter

IAPAC Mon 2007 Jan;13(1):27

View Article

Download full-text PDF

Source
January 2007
1 Read

Frequent methamphetamine use, primary NNRTI resistance.

Authors:
Michael Carter

IAPAC Mon 2007 Jan;13(1):12

View Article

Download full-text PDF

Source
January 2007
1 Read

Delaying maternal NVP-based ART more effective.

Authors:
Keith Alcorn

IAPAC Mon 2007 Jan;13(1):11-2

View Article

Download full-text PDF

Source
January 2007
2 Reads

48-week study results show DRV's staying power.

Authors:
Edwin J Bernard

IAPAC Mon 2007 Jan;13(1):10-1

View Article

Download full-text PDF

Source
January 2007
1 Read

'The sufficiency of hope'.

Authors:
José M Zuniga

IAPAC Mon 2007 Jan;13(1):4-6

View Article

Download full-text PDF

Source
January 2007
1 Read

Focus on hepatitis. Weight-based RBV dosing = impressive treatment success rates.

Authors:
Gus Cairns

IAPAC Mon 2006 Dec;12(12):446

View Article

Download full-text PDF

Source
December 2006
1 Read

HAART, hubris, and humility. Decade of HAART. September 25-26, 2006--San Francisco.

Authors:
Mark Mascolini

IAPAC Mon 2006 Dec;12(12):424-35

View Article

Download full-text PDF

Source
December 2006
1 Read

Micronutrient deficiencies less common in patients on ART.

Authors:
Derek Thaczuk

IAPAC Mon 2006 Dec;12(12):419-20

View Article

Download full-text PDF

Source
December 2006
8 Reads

Standing under the arch.

Authors:
José M Zuniga

IAPAC Mon 2006 Dec;12(12):416-7

View Article

Download full-text PDF

Source
December 2006
1 Read

Focus on hepatitis. Baseline HCV VL, CD4 percentage predict HCV treatment response.

Authors:
Liz Highleyman

IAPAC Mon 2006 Oct;12(10):375-6

View Article

Download full-text PDF

Source
October 2006
2 Reads

After Toronto, 46th ICAAC offers back to basics.

IAPAC Mon 2006 Oct;12(10):354-65

After the marathon-like challenge presented by the 16th International AIDS Conference held in Toronto a month prior--a challenge that tested the stamina of even the youngest and fittest of conference-goers--the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held September 27-30, 2006, in San Francisco, was a welcome relief in its staid and singular focus on the presentation of data offering insights into the challenges a variety of patients and their physicians are facing in the second decade of highly active antiretroviral therapy (HAART), as well as reviews of how to make optimal use of antiretroviral regimens constructed from within the existing HAART armamentarium. The big news at this year's ICAAC, however, was on the antiretroviral pipeline, with previews of how a new generation of drugs may help make the difference between life and death for countless millions of men, women, and children living with HIV/AIDS. Read More

View Article

Download full-text PDF

Source
October 2006
1 Read

Developed world physicians beta-test certification exam.

Authors:

IAPAC Mon 2006 Oct;12(10):342

View Article

Download full-text PDF

Source
October 2006
1 Read

'Feminizing' our response to AIDS.

Authors:
José M Zuniga

IAPAC Mon 2006 Oct;12(10):340-2

View Article

Download full-text PDF

Source
October 2006
1 Read

Focus on hepatitis. New risk factors identified for severe liver toxicity.

Authors:
Edwin J Bernard

IAPAC Mon 2006 Nov;12(11):403-4

View Article

Download full-text PDF

Source
November 2006
1 Read

WHO's Director-General Elect lays out her vision.

Authors:
Margaret Chan

IAPAC Mon 2006 Nov;12(11):394-9

View Article

Download full-text PDF

Source
November 2006
1 Read

TMC125 study highlights failing NNRTI regimen task.

Authors:
Keith Alcorn

IAPAC Mon 2006 Nov;12(11):390

View Article

Download full-text PDF

Source
November 2006
1 Read

Eppur si salva!

Authors:
José M Zuniga

IAPAC Mon 2006 Nov;12(11):388-9

View Article

Download full-text PDF

Source
November 2006
1 Read

HIV/HCV coinfection exacerbates ESLD risk.

Authors:
Liz Highleyman

IAPAC Mon 2006 Sep;12(9):329

View Article

Download full-text PDF

Source
September 2006
2 Reads

Metabolic complications of HIV therapy.

IAPAC Mon 2006 Sep;12(9):302-17

View Article

Download full-text PDF

Source
September 2006
1 Read

Adherence to NNRTI-based regimens less demanding?

Authors:
Derek Thaczuk

IAPAC Mon 2006 Sep;12(9):294

View Article

Download full-text PDF

Source
September 2006
2 Reads

There's something about Galen.

Authors:
José M Zuniga

IAPAC Mon 2006 Sep;12(9):292-3

View Article

Download full-text PDF

Source
September 2006
2 Reads

Focus on hepatitis. Low CD4 count + HCV coinfection = acute kidney failure.

Authors:

IAPAC Mon 2006 Aug;12(8):276

View Article

Download full-text PDF

Source
August 2006
1 Read

AIDS at 25.

IAPAC Mon 2006 Aug;12(8):270

Federal University of Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
August 2006
3 Reads

ZDV link to early signs of CVD?

Authors:
Edwin J Bernard

IAPAC Mon 2006 Aug;12(8):262-3

View Article

Download full-text PDF

Source
August 2006
1 Read

Reasons to hope...

Authors:
José M Zuniga

IAPAC Mon 2006 Aug;12(8):256-7

View Article

Download full-text PDF

Source
August 2006
1 Read

Focus on hepatitis. HCV protease inhibitor does well in early clinical trial.

Authors:
Michael Carter

IAPAC Mon 2006 Feb;12(2):50-1

View Article

Download full-text PDF

Source
February 2006
1 Read

LPV monotherapy: 72-week data.

Authors:

IAPAC Mon 2006 Jan;12(1)

View Article

Download full-text PDF

Source
January 2006
1 Read

Focus on hepatitis. HIV/HCV coinfection and ART.

Authors:
Michael Carter

IAPAC Mon 2006 May;12(5):157

View Article

Download full-text PDF

Source
May 2006
2 Reads

Workshop explores racial PK differences, TDF-PI interaction.

Authors:
Yasmin Halima

IAPAC Mon 2006 May;12(5):148-9

View Article

Download full-text PDF

Source
May 2006
1 Read

Treat, train, retain.

Authors:
José M Zuniga

IAPAC Mon 2006 May;12(5):144-6

View Article

Download full-text PDF

Source
May 2006
1 Read

Focus on hepatitis. Non-invasive probe can stage liver disease.

Authors:
Chris Gadd

IAPAC Mon 2006 Feb;12(2):50

View Article

Download full-text PDF

Source
February 2006
1 Read

New directions in HIV prevention: serosorting and universal testing.

Authors:
Gus Cairns

IAPAC Mon 2006 Feb;12(2):42-5

The use of HIV testing and information about one's serostatus as an HIV prevention tool remains a complex and controversial area of debate, largely due to issues of trust: trust in the confidentiality of information, trust that health care providers will not test without consent, and trust that partners are telling the truth about their status. Read More

View Article

Download full-text PDF

Source
February 2006
2 Reads

Corruption and HIV/AIDS. Accountability in a time of crisis.

Authors:
Toby Kasper

IAPAC Mon 2006 Feb;12(2):40

View Article

Download full-text PDF

Source
February 2006
2 Reads

Corruption and HIV/AIDS. Corruption in Kenya's National AIDS Control Council.

IAPAC Mon 2006 Feb;12(2):39-41

View Article

Download full-text PDF

Source
February 2006
1 Read

The link between corruption and HIV/AIDS.

IAPAC Mon 2006 Feb;12(2):37-9

View Article

Download full-text PDF

Source
February 2006
2 Reads

Statins may not affect CD4 response.

Authors:
Chris Gadd

IAPAC Mon 2006 Feb;12(2):33

View Article

Download full-text PDF

Source
February 2006
1 Read

Personal metrics.

Authors:
José M Zuniga

IAPAC Mon 2006 Feb;12(2):31-2

View Article

Download full-text PDF

Source
February 2006
1 Read

Focus on hepatitis. Increased RBV dose for better HCV treatment response.

Authors:
Edwin J Bernard

IAPAC Mon 2006 Jan;12(1):18

View Article

Download full-text PDF

Source
January 2006
1 Read

Adherence: what do our patients think?

Authors:
Judith Feinberg

IAPAC Mon 2006 Jan;12(1):12-5

University of Cincinnati, Ohio, USA.

View Article

Download full-text PDF

Source
January 2006
1 Read

48-week RESIST data confirms TPV benefit.

Authors:
Chris Gadd

IAPAC Mon 2006 Jan;12(1)

View Article

Download full-text PDF

Source
January 2006
1 Read

A coeur vaillant...

Authors:
José M Zuniga

IAPAC Mon 2006 Jan;12(1):7-8

View Article

Download full-text PDF

Source
January 2006
1 Read

Focus on hepatitis. Higher US HCV rate.

Authors:
Liz Highleyman

IAPAC Mon 2006 Jun;12(6):194

View Article

Download full-text PDF

Source
June 2006
3 Reads

Butting heads with resistance.

Authors:
Robert W Shafer

IAPAC Mon 2006 Jun;12(6):180-9

Stanford University School of Medicine, Stanford, California, USA.

View Article

Download full-text PDF

Source
June 2006
2 Reads

ABC in the news.

Authors:
Michael Carter

IAPAC Mon 2006 Jun;12(6):178-9

View Article

Download full-text PDF

Source
June 2006
3 Reads

FDA approves new PI.

Authors:
Chris Gadd

IAPAC Mon 2006 Jun;12(6):174

View Article

Download full-text PDF

Source
June 2006
1 Read

Intensified remembering.

Authors:
José M Zuniga

IAPAC Mon 2006 Jun;12(6):172-3

View Article

Download full-text PDF

Source
June 2006
1 Read